KLRK1 and systemic sclerosis: Collectively, our data demonstrate a peculiar NK cell phenotype in SSc patients characterized by (i) a decreased expression of CX3CR1 and CXCR4 in NK cells (percentages and intensity of expression) and (ii) a lower expression level of the NKG2D activating receptor and of the CD69 activation marker.